Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer
|
May 16, 2024
An engineering feat of small proportions
Gerald M Higa
Expert Review of Anticancer Therapy
|
July 11, 2009
Biological mechanisms of bevacizumab-associated adverse events
Gerald M Higa, Jame Abraham
Expert Review of Anticancer Therapy
|
May 13, 2008
Ixabepilone: a new microtubule-targeting agent for breast cancer
Gerald M Higa, Jame Abraham
Clinical Medicine Insights. Oncology
|
April 16, 2016
Molecular Biology and Clinical Mitigation of Cancer Treatment-Induced Neuropathy
Gerald M Higa, Corbin Sypult
Expert Review of Anticancer Therapy
|
September 26, 2007
Lapatinib in the treatment of breast cancer
Gerald M Higa, Jame Abraham
International Journal of Breast Cancer
|
December 11, 2013
Sex hormone receptor repertoire in breast cancer
Gerald M Higa, Ryan G Fell
Journal of Pain Research
|
April 12, 2022
Spoken and Unspoken Matters Regarding the Use of Opioids in Cancer
Janna Baker Rogers, Gerald M Higa
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
January 21, 2010
Chemotherapy-induced nausea and vomiting: antiemetic trials that impacted clinical practice
Michael E Trigg, Gerald M Higa
Expert Review of Anticancer Therapy
|
September 15, 2010
Biological considerations and clinical applications of new HER2-targeted agents
Gerald M Higa, Vikramjit Singh, Jame Abraham
Scientifica
|
November 27, 2013
Adjudication of the alleged role of vitamin d in the antimicrobial pathway
Gerald M Higa, Jason Hicks, Christopher Isabella
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer
|
May 16, 2024
An engineering feat of small proportions
Gerald M Higa
Expert Review of Anticancer Therapy
|
July 11, 2009
Biological mechanisms of bevacizumab-associated adverse events
Gerald M Higa, Jame Abraham
Expert Review of Anticancer Therapy
|
May 13, 2008
Ixabepilone: a new microtubule-targeting agent for breast cancer
Gerald M Higa, Jame Abraham
Clinical Medicine Insights. Oncology
|
April 16, 2016
Molecular Biology and Clinical Mitigation of Cancer Treatment-Induced Neuropathy
Gerald M Higa, Corbin Sypult
Expert Review of Anticancer Therapy
|
September 26, 2007
Lapatinib in the treatment of breast cancer
Gerald M Higa, Jame Abraham
International Journal of Breast Cancer
|
December 11, 2013
Sex hormone receptor repertoire in breast cancer
Gerald M Higa, Ryan G Fell
Journal of Pain Research
|
April 12, 2022
Spoken and Unspoken Matters Regarding the Use of Opioids in Cancer
Janna Baker Rogers, Gerald M Higa
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
January 21, 2010
Chemotherapy-induced nausea and vomiting: antiemetic trials that impacted clinical practice
Michael E Trigg, Gerald M Higa
Expert Review of Anticancer Therapy
|
September 15, 2010
Biological considerations and clinical applications of new HER2-targeted agents
Gerald M Higa, Vikramjit Singh, Jame Abraham
Scientifica
|
November 27, 2013
Adjudication of the alleged role of vitamin d in the antimicrobial pathway
Gerald M Higa, Jason Hicks, Christopher Isabella
Page
of 4